首页> 外文期刊>Pakistan journal of medical sciences. >Research on the Correlation of Serum PCT and Plasma?GSN Levels with the Prognosis of Urosepsis Patients
【24h】

Research on the Correlation of Serum PCT and Plasma?GSN Levels with the Prognosis of Urosepsis Patients

机译:血清PCT和血浆的相关性研究与尿溶质患者预后的GSN水平

获取原文
           

摘要

Objective: To explore the correlation of procalcitonin (PCT) and gelsolin (GSN) with the prognosis ofurosepsis patients.Method: The data of 71 urosepsis patients from March 2015 to April 2019 who were admitted to andtreated in Affiliated Hospital of Hebei University were analyzed and compared with those of 92 healthypersons. Serum PCT and plasma GSN levels at different times after treatment were detected. According toprognosis, patients were classified into the good prognosis group or the poor prognosis group. The serumPCT and plasma GSN levels of both groups were compared.Result: The serum PCT level of the urosepsis group on the 1st, 3rd, 5th and 7th days was obviously higherthan that of the control group (P0.05). The plasma GSN levels of the urosepsis group on the 1st, 3rd, 5thand 7th days were obviously lower than those of the control group (P0.05).The serum PCT level of the poorprognosis group on the 1st, 3rd, 5th and 7th days was obviously higher than that of the good prognosis group(P0.05). The plasma GSN level of the poor prognosis group on the 1st, 3rd, 5th and 7th days was obviouslylower than that of the good prognosis group (P0.05). PCT was an independent risk factor influencing theprognosis of urosepsis patients and that GSN was a protective factor (P0.05).Conclusion: The serum PCT and plasma GSN levels can accurately predict the severity and prognosis ofurosepsis patients and reflect the disease state of early urosepsis patients. High PCT levels and low GSNlevels indicate poor prognosis, and clinicians should consider these values.
机译:目的:探讨ProCalcitonin(PCT)和露珠蛋白(GSN)与尿精患者预后的相关性。方法:2015年3月至2019年3月至2019年4月的数据进行了分析,并分析了河北大学附属医院的71次尿溶质血症患者与92个健康问题相比。检测到治疗后不同时间的血清PCT和血浆GSN水平。根据胸膜病变,患者分为良好的预后组或预后差。比较两组的血清和血浆GSN水平。结果:第1,第3,第5天和第7天的尿溶质组血清PCT水平明显增加对照组(P <0.05)。尿溶质血症组的血浆GSN水平在第1,第3天,第7天明显低于对照组(P <0.05)。第1,第3,第5天的贫病群体的血清PCT水平明显高于良好预后组(P <0.05)。第1,第3,第5天的预后差的血浆GSN水平明显低于良好预后组(P <0.05)。 PCT是影响尿溶质患者的预期的独立危险因素,并且GSN是一种保护因子(P <0.05)。结论:血清PCT和血浆GSN水平可以准确地预测患有血症患者的严重程度和预后,并反映早期尿溶症的疾病状态耐心。高PCT水平和低GSNLEVELS表明预后差,临床医生应考虑这些值。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号